Valneva SE (VALN) Other Operating Expenses (2021 - 2026)
Valneva SE (VALN) posted quarterly Other Operating Expenses of $2.2 million for Q1 2026, down 10.46% year-on-year from $2.5 million in Q1 2025, and down 18.74% on a QoQ basis from $2.7 million in Q4 2025.
Valneva SE (VALN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Other Operating Expenses for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- Quarterly Other Operating Expenses fell 10.46% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (down 49.0% YoY) and the FY2025 annual result came in at $11.8 million, down 49.77% from the prior year.
- Other Operating Expenses eased to $2.2 million in Q1 2026 per VALN's latest filing, from $2.7 million in the prior quarter.
- Over the last five years, Other Operating Expenses for VALN reached as high as $12.0 million in Q2 2023 and fell as low as $1.7 million in Q2 2022.
- A 5-year average of $4.5 million and a median of $3.9 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses sank 79.58% — and 2023, when it soared 595.77%.
- Year by year, Other Operating Expenses stood at $5.4 million in 2022, then fell by 4.8% to $5.1 million in 2023, then gained by 29.24% to $6.6 million in 2024, then sank by 59.08% to $2.7 million in 2025, then retreated by 18.74% to $2.2 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.2 million, $2.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 3.94 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 9.71 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Jun 30, 2023 | 11.98 Mn |
| Mar 31, 2023 | 3.97 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 7.90 Mn |
| Sep 30, 2021 | 6.42 Mn |
| Jun 30, 2021 | 8.43 Mn |